Equities

Utah Medical Products Inc

Utah Medical Products Inc

Actions
  • Price (USD)89.00
  • Today's Change-0.99 / -1.10%
  • Shares traded80.84k
  • 1 Year change+11.81%
  • Beta0.2363
Data delayed at least 15 minutes, as of Sep 17 2021 21:00 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company's product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. UTMD markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit, the labor and delivery department and the women's health center in hospitals, as well as products sold to outpatient clinics and physician's offices.

  • Revenue in USD (TTM)46.06m
  • Net income in USD13.06m
  • Incorporated1978
  • Employees181.00
  • Location
    Utah Medical Products Inc7043 S Cottonwood StMIDVALE 84047-1048United StatesUSA
  • Phone+1 (801) 566-1200
  • Fax+1 (801) 566-7305
  • Websitehttp://www.utahmed.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
DarioHealth Corp12.98m-50.91m237.24m127.00--1.99--18.28-4.33-4.331.127.230.17523.1412.62102,189.00-65.16-131.39-73.83-186.8028.4125.00-372.00-300.355.26-219.140.00--0.224955.89-58.46--1.41--
Apollo Endosurgery Inc56.15m-13.72m254.88m158.00--93.66--4.54-0.5347-0.53472.200.09480.83492.326.64355,398.70-20.40-36.38-27.19-52.7054.8656.71-24.44-58.143.20-2.570.9529---17.09-9.1117.57---37.83--
iCAD Inc34.05m-8.32m261.37m113.00--5.12--7.68-0.3469-0.34691.432.040.59493.143.68301,327.40-14.54-23.14-19.08-36.6871.4172.08-24.44-32.203.51-22.190.00---5.24-6.50-29.95---13.38--
InfuSystem Holdings Inc99.13m15.09m264.72m282.0018.685.928.982.670.6890.6894.532.171.109.876.17351,535.5016.773.3820.964.2760.2761.8315.223.531.135.050.4207--20.066.661,173.4844.1510.55--
Beyond Air Inc644.03k-22.88m278.03m45.00--8.08--431.71-1.19-1.190.03331.440.0181--6.9314,311.78-64.40---73.07-------3,551.98-----33.360.1267---37.19---11.77------
Co-Diagnostics Inc96.35m46.22m289.48m37.006.413.326.233.001.561.563.253.021.462.2410.642,603,969.0070.2646.3974.6358.7083.4977.6647.9828.2318.23--0.00--34,580.54494.97785.63--45.57--
CVRx Inc9.07m-33.00m308.65m--------34.04-1.62-1.620.44570.5432----------------73.06---363.96--2.04-6.160.6373---3.26--3.58------
Utah Medical Products, Inc.46.06m13.06m324.55m181.0024.913.0215.987.053.573.5012.6029.450.41812.7710.97254,458.6011.8514.2512.2814.9161.8762.0428.3531.8914.55--0.0029.86-10.080.9869-23.51-1.3628.441.88
Accuray Incorporated396.29m-6.31m338.79m995.00--4.924,033.230.8549-0.0695-0.06954.280.7580.81621.824.50398,280.40-1.30-0.684-2.12-1.2940.2539.01-1.59-0.75381.181.240.7163--3.49-0.1263-264.91---22.06--
ConforMIS Inc103.00m13.73m340.31m259.00--2.7118.833.30-0.0487-0.04870.89580.67580.87142.5412.05397,687.3011.62-45.3214.38-54.7167.1844.2813.33-52.628.84--0.1409---11.190.554214.70---6.89--
Sientra Inc85.20m-100.29m344.50m255.00------4.04-1.86-1.891.60-0.53370.45350.87193.72334,117.70-53.39-47.54-79.31-73.3153.3759.63-117.71-124.501.47-1.001.85---14.8813.3315.79--29.05--
Acutus Medical Inc14.05m-118.60m347.46m291.00--3.73--24.74-5.06-5.060.56032.690.13211.826.6648,271.48-111.56---145.10---74.26---844.29--4.89-19.920.3712--198.45---5.09------
Cytosorbents Corp45.13m-10.36m378.61m195.00--5.09--8.39-0.2402-0.24021.051.720.61213.839.36231,411.80-14.06-44.21-17.13-58.4675.8968.73-22.96-57.046.80--0.00--64.3553.6359.32--21.11--
Apyx Medical Corp38.28m-17.87m394.03m266.00--6.87--10.29-0.5212-0.41431.121.670.51932.375.01143,909.80-24.26-23.87-28.23-27.4267.4564.95-46.72-78.045.24-1,170.150.0052---1.86-1.2621.04--6.65--
Retractable Technologies, Inc.151.66m51.38m399.95m182.007.835.378.122.641.501.504.442.201.367.438.75833,280.6043.778.2959.4110.6351.0636.9232.158.491.79--0.0292--95.8622.60988.6735.1270.40--
Iradimed Corp35.28m3.77m410.81m110.00110.856.3380.2611.640.30090.36482.825.270.48861.868.41320,723.305.2210.105.6711.1175.3377.0310.6815.8010.19--0.000.00-17.650.0782-94.09-40.3415.13--
Data as of Sep 17 2021. Currency figures normalised to Utah Medical Products Inc's reporting currency: US Dollar USD

Institutional shareholders

53.17%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 30 Jun 2021519.90k14.26%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 2021281.63k7.72%
Renaissance Technologies LLCas of 30 Jun 2021243.91k6.69%
BlackRock Fund Advisorsas of 30 Jun 2021201.02k5.51%
The Vanguard Group, Inc.as of 30 Jun 2021189.98k5.21%
Dimensional Fund Advisors LPas of 30 Jun 2021152.19k4.17%
Rice, Hall, James & Associates LLCas of 30 Jun 2021112.89k3.10%
JPMorgan Investment Management, Inc.as of 30 Jun 202188.80k2.44%
Russell Investment Management LLCas of 30 Jun 202182.63k2.27%
SSgA Funds Management, Inc.as of 30 Jun 202166.05k1.81%
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image